Land: Nederland
Taal: Nederlands
Bron: CBG-MEB (College ter Beoordeling van Geneesmiddelen)
ATENOLOL 100 mg/stuk
Sandoz B.V. Veluwezoom 22 1327 AH ALMERE
C07AB03
ATENOLOL 100 mg/stuk
Tablet
CELLULOSE, MICROKRISTALLIJN (E 460(i)) ; MAGNESIUMSTEARAAT (E 470b) ; MAÏSZETMEEL ; NATRIUMZETMEELGLYCOLAAT ; POVIDON K 25 (E 1201) ; SILICIUMDIOXIDE (E 551), CELLULOSE, MICROKRISTALLIJN (E 460) ; MAGNESIUMSTEARAAT (E 470b) ; MAÏSZETMEEL ; NATRIUMZETMEELGLYCOLAAT ; POVIDON K 25 (E 1201) ; SILICIUMDIOXIDE (E 551), CELLULOSE, MICROKRISTALLIJN (E 460) ; MAGNESIUMSTEARAAT (E 470b) ; MAÏSZETMEEL ; NATRIUMZETMEELGLYCOLAAT (E468) ; POVIDON K 25 (E 1201) ; SILICIUMDIOXIDE (E 551),
Oraal gebruik
Atenolol
Hulpstoffen: CELLULOSE, MICROKRISTALLIJN (E 460); MAGNESIUMSTEARAAT (E 470b); MAÏSZETMEEL; NATRIUMZETMEELGLYCOLAAT (E468); POVIDON K 25 (E 1201); SILICIUMDIOXIDE (E 551);
1990-04-20
Sandoz B.V. Page 1/9 Atenolol Sandoz ® 25/50/100, tabletten 25/50/100 mg RVG 24399-14705-14706 1313-V13 1.3.1.3 Bijsluiter Maart 2021 PACKAGE LEAFLET: INFORMATION FOR THE PATIENT ATENOLOL SANDOZ ® 25, TABLETTEN 25 MG ATENOLOL SANDOZ ® 50, TABLETTEN 50 MG ATENOLOL SANDOZ ® 100, TABLETTEN 100 MG ATENOLOL READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START USING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. - Keep this leaflet. You may need to read it again. - If you have any further questions, ask your doctor or pharmacist. - This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. - If you get any side effects, talk to your doctor, or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. WHAT IS IN THIS LEAFLET 1. What [Nationally completed name] is and what it is used for 2. What you need to know before you take [Nationally completed name] 3. How to take [Nationally completed name] 4. Possible side effects 5. How to store [Nationally completed name] 6. Contents of the pack and other information 1. WHAT [NATIONALLY COMPLETED NAME] IS AND WHAT IT IS USED FOR [Nationally completed name] contains a medicine called atenolol. This belongs to a group of medicines called beta-blockers. [Nationally completed name] is used to: • treat high blood pressure (hypertension) • treat chest pain caused by “chronic stable angina pectoris” • treat some types of uneven heart beats (arrhythmias) • help prevent another heart attack from happening. It works by making your heart beat more slowly and with less force. 2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE [NATIONALLY COMPLETED NAME] DO NOT TAKE [NATIONALLY COMPLETED NAME] IF: • You are allergic to atenolol or any of the other ingredients of this medicine (listed in section 6). • You have ever had any of the following heart problems: o heart failure which is not under control (this usually makes you breathless and caus Lees het volledige document
Sandoz B.V. Page 1/11 Atenolol Sandoz 25/50/100, tabletten 25/50/100 mg RVG 24399-14705-14706 1311-V12 1.3.1.1 Samenvatting van de Productkenmerken Maart 2021 SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT Atenolol Sandoz 25, tabletten 25 mg Atenolol Sandoz 50, tabletten 50 mg Atenolol Sandoz 100, tabletten 100 mg 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains 25 mg atenolol. Each tablet contains 50 mg atenolol. Each tablet contains 100 mg atenolol. For the full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Tablet. _25 mg tablets: _ White, round biconvex tablets, on one side an inscription ‘25’ and` on the other side a score. Diameter: 7 mm. _50 mg tablets: _ White, round biconvex tablets, on one side an inscription ‘50’ and on the other side a score. Diameter: 8 mm. _100 mg tablets: _ White, round biconvex tablets, on one side an inscription ‘100’ and on the other side a score. Diameter: 10 mm. The score line is only to facilitate breaking for ease of swallowing and not to divide into equal doses. 4. CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS • Hypertension • Chronic stable angina pectoris • Secondary prevention after acute myocardial infarction • Supraventricular arrhythmias: - paroxysmal supraventricular tachycardia (in therapeutic or prophylactic treatment) - atrial fibrillation and atrial flutter: in case of inadequate response to maximum doses of cardiac glycosides; in cases where cardiac glycosides may be contra-indicated or may be associated with an unfavourable risk/benefit ratio. • Ventricular arrhythmias: - ventricular extrasystoles (prophylactic or therapeutic treatment), if the extrasystoles are Sandoz B.V. Page 2/11 Atenolol Sandoz 25/50/100, tabletten 25/50/100 mg RVG 24399-14705-14706 1311-V12 1.3.1.1 Samenvatting van de Productkenmerken Maart 2021 the result of increased sympathetic activity - ventricular tachycardias and ventricular fibrillation (prophylactic treatment), especially when the ventricular abnormality i Lees het volledige document